ARKG vs DIVO
ARK Genomic Revolution ETF vs Amplify CWP Enhanced Dividend Income ETF
- • DIVO has the lower expense ratio at 0.56% vs 0.75% for ARKG.
- • DIVO pays a higher dividend yield (2.31%).
Side-by-side metrics
| Metric | ARKG | DIVO |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.56% |
Dividend yield Trailing 12-month yield. | 0.00% | 2.31% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $8.01B |
YTD return | 66.55% | 10.78% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.53 |
P/E ratio | — | 22.07 |
Last price | $47.17 | $47.41 |
Inception | — | — |
Issuer | ARK | Amplify |
ARKG top holdings
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
DIVO top holdings
| MSFT | Microsoft Corp | 5.86% |
| AMGN | Amgen Inc | 5.74% |
| V | Visa Inc Class A | 5.42% |
| AGPXX | Invesco Shrt-Trm Inv Gov&Agcy Instl | 5.34% |
| AAPL | Apple Inc | 5.08% |
| JPM | JPMorgan Chase & Co | 4.94% |
| GS | The Goldman Sachs Group Inc | 4.88% |
| CAT | Caterpillar Inc | 4.51% |
| SOFR | Amplify Samsung SOFR ETF | 4.16% |
| AXP | American Express Co | 4.12% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About DIVO
DIVO (Amplify CWP Enhanced Dividend Income ETF) is Quality dividend payers with tactical covered calls. Managed by Amplify, the fund carries $8.0B in assets under management, an expense ratio of 0.56%, a dividend yield of 2.31%. Its largest holding is Microsoft Corp (MSFT), which represents 5.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.4%.